{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52028464",
    "licUnit": "1",
    "validDate": "2028-07-19 00:00:00.000",
    "issueDate": "2023-07-19 00:00:00.000",
    "oriIssueDate": "2023-07-19",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202846402",
    "prodNameC": "猛健樂注射劑5毫克\/0.5毫升",
    "prodNameE": "MOUNJARO Injection 5mg\/0.5mL",
    "indicationsName": [
        "1. 血糖控制：\n作為飲食及運動療法之外的輔助治療，用於改善第二型糖尿病成人病人之血糖控制。說明: MOUNJARO可做為單一療法或與其他糖尿病治療藥物合併使用。\n2. 肥胖與過重之體重控制\n(1) 做為低熱量飲食及增加體能活動之輔助療法，適用對象為成人且初始身體質量指數(BMI)為 \n≥ 30 kg\/m2(肥胖)，\n或 ≥ 27kg\/m2至 < 30 kg\/m2 (過重)且至少患有一項體重相關共病，例如高血壓、血脂異常、糖尿病前期或第二型糖尿病、阻塞性睡眠呼吸中止或心血管疾病。\n(2) 做為低熱量飲食及增加體能活動之輔助療法，適用於具有中度至重度阻塞性睡眠呼吸中止症且身體質量指數(BMI) ≥30 kg\/m2之成人，改善睡眠呼吸中止的嚴重程度。\n使用限制\n(1) MOUNJARO尚未在有胰臟炎病史的病人中進行研究。\n(2) MOUNJARO不可用於第一型糖尿病病人。\n(3) MOUNJARO含有tirzepatide。不建議與其他含有tirzepatide的藥品或任何升糖素類似胜肽-1 (GLP-1)受體促效劑併用。\n(4) 尚未確定MOUNJARO併用其他用於體重控制之藥品(包括處方藥、非處方藥和草本製劑)的安全性和療效。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "自動注射筆內含0.5毫升玻璃預充填式針筒，100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "A",
    "mainCategory": "A",
    "drBaseId": "0F199F33-339F-417C-BF23-735D32D5558E",
    "subCategory": [
        "A01"
    ],
    "ingredientsDesc": [
        "Tirzepatide"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "5F 免除銜接性試驗"
    ],
    "applicantName": "台灣禮來股份有限公司",
    "applicantAddr": "臺北市信義區松高路9號14樓、11號14樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2028-07-19",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "1F1969F3-9B05-4666-8D09-33C495330B73",
            "factoryCode": "1",
            "factoryName": "ELI LILLY AND COMPANY",
            "factoryAddr": "INDIANAPOLIS, INDIANA 46285, U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FUS0073100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "F7F72570-BEA2-4F25-ADB0-6F3E3F7A559D",
            "factoryCode": "2",
            "factoryName": "ELI LILLY ITALIA S.P.A.",
            "factoryAddr": "VIA GRAMSCI 731-733 50019 SESTO FIORENTINO",
            "factoryCompanyAddr": null,
            "countryCode": "IT",
            "processCode": [
                {
                    "value": "02",
                    "name": "包裝"
                }
            ],
            "processCodeStr": "02;包裝",
            "factoryKind": "M",
            "factoryNo": "FIT0058100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "2406003400",
            "ingredientsName": "Tirzepatide",
            "ingredientsDesc": "Tirzepatide",
            "concentDesc": "",
            "concent": "5.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "A10BX16"
        }
    ],
    "licBaseId": "0906990F-DB19-4ED7-AD7F-B6A7BE6E56BB"
}